Instytut Podstawowych Problemów Techniki
Polskiej Akademii Nauk

Partnerzy

Katarzyna Piwocka

Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)

Ostatnie publikacje
1.  Was H., Barszcz K., Czarnecka J., Kowalczyk A., Bernas T., Uzarowska E., Koza P., Klejman A., Piwocka K., Kaminska B., Sikora E., Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice, Oncotarget, ISSN: 1949-2553, DOI: 10.18632/oncotarget.14066, Vol.8, No.6, pp.9303-9322, 2017

Streszczenie:
Anticancer therapies that induce DNA damage tend to trigger senescence in cancer cells, a process known as therapy-induced senescence (TIS). Such cells may undergo atypical divisions, thus contributing to tumor re-growth. Accumulation of senescent cancer cells reduces survival of patients after chemotherapy. As senescence interplays with autophagy, a dynamic recycling process, we sought to study whether inhibition of autophagy interferes with divisions of TIS cells. We exposed human colon cancer HCT116 cells to repeated cycles of a chemotherapeutic agent - doxorubicin (doxo) and demonstrated induction of hallmarks of TIS (e.g. growth arrest, hypertrophy, poliploidization and secretory phenotype) and certain properties of cancer stem cells (increased NANOG expression, percentages of CD24+ cells and side population). Colonies of small and highly proliferative progeny appeared shortly after drug removal. Treatment with bafilomycin A1 (BAF A1), an autophagy inhibitor, postponed short term in vitro cell re-population. It was associated with reduction in the number of diploid and increase in the number of poliploid cells. In a long term, a pulse of BAF A1 resulted in reactivation of autophagy in a subpopulation of HCT116 cells and increased proliferation. Accordingly, the senescent HCT116 cells treated with BAF A1 when injected into NOD/SCID mice formed tumors, in contrast to the controls. Our results suggest that senescent cancer cells that appear during therapy, can be considered as dormant cells that contribute to cancer re-growth, when chemotherapeutic treatment is stopped. These data unveil new mechanisms of TIS-related cancer maintenance and re-population, triggered by a single pulse of BAF A1 treatment.

Słowa kluczowe:
colon cancer, chemotherapy, senescence, autophagy, angiogenesis

Afiliacje autorów:
Was H. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Barszcz K. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Czarnecka J. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Kowalczyk A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Bernas T. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Uzarowska E. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Koza P. - inna afiliacja
Klejman A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Piwocka K. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Kaminska B. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Sikora E. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
40p.
2.  Alster O., Bielak-Żmijewska A., Mosieniak G., Moreno-Villaneuva M., Dudka-Ruszkowska W., Wojtala A., Kusio-Kobiałka M., Korwek Z., Burkle A., Piwocka K., Siwicki J.K., Sikora E., The Role of Nibrin in Doxorubicin-Induced Apoptosis and Cell Senescence in Nijmegen Breakage Syndrome Patients Lymphocytes, PLOS ONE, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0104964, Vol.9, No.8, pp.e104964-1-13, 2014

Streszczenie:
Nibrin plays an important role in the DNA damage response (DDR) and DNA repair. DDR is a crucial signaling pathway in apoptosis and senescence. To verify whether truncated nibrin (p70), causing Nijmegen Breakage Syndrome (NBS), is involved in DDR and cell fate upon DNA damage, we used two (S4 and S3R) spontaneously immortalized T cell lines from NBS patients, with the founding mutation and a control cell line (L5). S4 and S3R cells have the same level of p70 nibrin, however p70 from S4 cells was able to form more complexes with ATM and BRCA1. Doxorubicin-induced DDR followed by cell senescence could only be observed in L5 and S4 cells, but not in the S3R ones. Furthermore the S3R cells only underwent cell death, but not senescence after doxorubicin treatment. In contrary to doxorubicin treatment, cells from all three cell lines were able to activate the DDR pathway after being exposed to γ-radiation. Downregulation of nibrin in normal human vascular smooth muscle cells (VSMCs) did not prevent the activation of DDR and induction of senescence. Our results indicate that a substantially reduced level of nibrin or its truncated p70 form is sufficient to induce DNA-damage dependent senescence in VSMCs and S4 cells, respectively. In doxorubicin-treated S3R cells DDR activation was severely impaired, thus preventing the induction of senescence.

Afiliacje autorów:
Alster O. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Bielak-Żmijewska A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Mosieniak G. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Moreno-Villaneuva M. - University of Konstanz (DE)
Dudka-Ruszkowska W. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Wojtala A. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Kusio-Kobiałka M. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Korwek Z. - inna afiliacja
Burkle A. - University of Konstanz (DE)
Piwocka K. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
Siwicki J.K. - Institute of Oncology (PL)
Sikora E. - Nencki Institute of Experimental Biology, Polish Academy of Sciences (PL)
40p.

Kategoria A Plus

IPPT PAN

logo ippt            ul. Pawińskiego 5B, 02-106 Warszawa
  +48 22 826 12 81 (centrala)
  +48 22 826 98 15
 

Znajdź nas

mapka
© Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk 2024